ACCPL2026-08-03ACCPL2026-08-032026-08-03ResolutionOrAgendaDomain1ACCPL2026-08-03ResolutionOrAgendaDomain1ACCPL2026-08-032026-08-03ResolutionOrAgendaDomain2ACCPL2026-08-03ResolutionOrAgendaDomain2xbrli:pureACCPLAccretion Pharmaceuticals LimitedNew2026-08-0316:55:002026-08-03Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)3rd Annual General MeetingThursday2026-08-2711:00:00Registered Office: 29 Xcelon Industrial Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvadi, Sanand, Ahmedabad, Gujarat, India, 3822132Ordinary ResolutionAdoption of Financial Statements1. To receive, consider and adopt the Standalone Financial Statements as at 31 March, 2026 including the Audited Balance Sheet as at 31 March, 2026, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon.Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotation2. To appoint a director in place of Mr. Hardik Mukundbhai Prajapati (DIN: 09108403), Director, who retires by rotation and being eligible, offers himself for re-appointment.Executive DirectorMr. Hardik Mukundbhai Prajapati091084032023-11-292026-08-27